Cargando…

Effect of Diacerein on Insulin Secretion and Metabolic Control in Drug-Naïve Patients With Type 2 Diabetes: A randomized clinical trial

OBJECTIVE: To assess the effect of diacerein on insulin secretion and metabolic control in drug-naïve patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: A randomized, double-blind, placebo-controlled clinical trial was carried out in 40 drug-naïve adult patients with type 2 diabetes. A meta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramos-Zavala, Maria G., González-Ortiz, Manuel, Martínez-Abundis, Esperanza, Robles-Cervantes, José A., González-López, Roberto, Santiago-Hernández, Nestor J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120202/ https://www.ncbi.nlm.nih.gov/pubmed/21610123 http://dx.doi.org/10.2337/dc11-0357

Ejemplares similares

Response to Comment on: Ramos-Zavala et al. Effect of Diacerein on Insulin Secretion and Metabolic Control in Drug-Naïve Patients With Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2011;34:1591–1594
por: Ramos-Zavala, Maria G., et al.
Publicado: (2012)

Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
por: Villar, Miriam Méndez-del, et al.
Publicado: (2017)

Relationship between Serum Concentration of Uric Acid and Insulin Secretion among Adults with Type 2 Diabetes Mellitus
por: Robles-Cervantes, J. A., et al.
Publicado: (2011)

Ellagic Acid Effect on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Hidalgo-Lozada, Gladys Maribel, et al.
Publicado: (2022)

Effect of Avocado Soybean Unsaponifiables on Insulin Secretion and Insulin Sensitivity in Patients with Obesity
por: Martínez-Abundis, Esperanza, et al.
Publicado: (2013)

Insulin Resistance in Adult Primary Care Patients With a Surrogate Index, Guadalajara, Mexico, 2012
por: Espinel-Bermúdez, María Claudia, et al.
Publicado: (2015)

Comment on: Ramos-Zavala et al. Effect of Diacerein on Insulin Secretion and Metabolic Control in Drug-Naïve Patients With Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2011;34:1591–1594
por: Tobar, Natália, et al.
Publicado: (2012)

Atorvastatin and diacerein reduce insulin resistance and increase disease tolerance in rats with sepsis
por: da Silva, K. L. C., et al.
Publicado: (2018)

Ion-pair compounds of diacerein for enhancing skin permeability in vitro: the compatibility–permeability relationship of counter ion and diacerein
por: Liang, Yan, et al.
Publicado: (2022)

Effects of diacerein on cartilage and subchondral bone in early stages of osteoarthritis in a rabbit model
por: Permuy, María, et al.
Publicado: (2015)

Diacerein treatment prevents colitis-associated cancer in mice
por: Paulino, Daiane S M, et al.
Publicado: (2020)

An Update of Anthraquinone Derivatives Emodin, Diacerein, and Catenarin in Diabetes
por: Martorell, Miquel, et al.
Publicado: (2021)

The glucose-lowering effect of low-dose diacerein and its responsiveness metabolic markers in uncontrolled diabetes
por: Jangsiripornpakorn, Jintanan, et al.
Publicado: (2022)

Visible Spectrophotometric Estimation of Diacerein in Bulk and Pharmaceutical Dosage Forms
por: Sivakumar, R, et al.
Publicado: (2010)

Possible Protective Effect of Diacerein on Doxorubicin-Induced Nephrotoxicity in Rats
por: Refaie, Marwa M. M., et al.
Publicado: (2016)

In vitro antibiofilm and bacteriostatic activity of diacerein against Enterococcus faecalis
por: Fu, Chunyan, et al.
Publicado: (2023)

Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study
por: Wally, Verena, et al.
Publicado: (2013)

Diacerein protects against iodoacetate-induced osteoarthritis in the femorotibial joints of rats
por: Jain, Achint, et al.
Publicado: (2015)

Diacerein: A potential therapeutic drug for the management of experimental periodontitis in rats
por: Zaki, Basma Mostafa, et al.
Publicado: (2015)

Diacerein: A potential multi-target therapeutic drug for COVID-19
por: de Oliveira, Pedro Gonçalves, et al.
Publicado: (2020)

Reposition of the anti-inflammatory drug diacerein in an in-vivo colorectal cancer model
por: Abdel-Latif, Raghda T., et al.
Publicado: (2022)

Exploration of diacerein as a neuroprotective adjuvant to Adenium obesum: An in-vivo study
por: Sharma, Neeraj Kumar, et al.
Publicado: (2023)

Self-nanoemulsifying drug-delivery systems for potentiated anti-inflammatory activity of diacerein
por: Eltobshi, Amal Ahmed, et al.
Publicado: (2018)

A Stability-Indicating High Performance Liquid Chromatographic Method for the Determination of Diacerein in Capsules
por: Rao, Janhavi, et al.
Publicado: (2009)

Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO
por: Pavelka, Karel, et al.
Publicado: (2016)

Impaired macrophages and failure of steroidogenesis and spermatogenesis in rat testes with cytokines deficiency induced by diacerein
por: de Oliveira, Salmo Azambuja, et al.
Publicado: (2021)

Diacerein Inhibits Myopia Progression through Lowering Inflammation in Retinal Pigment Epithelial Cell
por: Tien, Peng-Tai, et al.
Publicado: (2021)

Postoperative efficacy of chondroprotectors and diacerein in dogs with osteoarthritis secondary to cranial cruciate ligament disease
por: Podestá, Florencia Sollier, et al.
Publicado: (2023)

Topical Diacerein Decreases Skin and Splenic CD11c(+) Dendritic Cells in Psoriasis
por: Brunner, Susanne M., et al.
Publicado: (2023)

The Changes in Early Phase Insulin Secretion in Newly Diagnosed, Drug Naive Korean Prediabetes Subjects
por: Rhee, Sang Youl, et al.
Publicado: (2010)

Effect of Diacerein on Metabolic Control and Inflammatory Markers in Patients with Type 2 Diabetes Using Antidiabetic Agents: A Randomized Controlled Trial
por: Tres, Glaucia S., et al.
Publicado: (2018)

Pharmacological treatment with diacerein combined with mechanical stimulation affects the expression of growth factors in human chondrocytes
por: Steinecker-Frohnwieser, Bibiane, et al.
Publicado: (2017)

Effect of antiretroviral therapy on decreasing arterial stiffness, metabolic profile, vascular and systemic inflammatory cytokines in treatment-naïve HIV: A one-year prospective study
por: Martínez-Ayala, Pedro, et al.
Publicado: (2023)

Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: a systematic review and network meta-analysis
por: Kongtharvonskul, Jatupon, et al.
Publicado: (2015)

Diacerein Improves Left Ventricular Remodeling and Cardiac Function by Reducing the Inflammatory Response after Myocardial Infarction
por: Torina, Anali Galluce, et al.
Publicado: (2015)

Inhibition of inflammation using diacerein markedly improved renal function in endotoxemic acute kidney injured mice
por: Yu, Guangzhe, et al.
Publicado: (2018)

Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex
por: Ablinger, Michael, et al.
Publicado: (2018)

Diacerein inhibits the pro-atherogenic & pro-inflammatory effects of IL-1 on human keratinocytes & endothelial cells
por: Mohan, Girish C., et al.
Publicado: (2017)

Fabrication, in vitro and ex vivo evaluation of proliposomes and liposomal derived gel for enhanced solubility and permeability of diacerein
por: Shah, Hassan, et al.
Publicado: (2021)

Diacerein versus non-steroidal anti-inflammatory drugs in the treatment of knee osteoarthritis: a meta-analysis
por: Zeng, Fan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qt2jime8o67tl6pbi1rh0mgfd6